COMMUNIQUÉS West-GlobeNewswire

Checkpoint Therapeutics Announces Issuance of Two New Patents for EGFR Inhibitor CK-101
13/03/2019
U.S. and European patent protections through at least August 2034 NEW YORK, March 13, 2019 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology [...]
Mustang Bio to Present at Oppenheimer’s 29th Annual Healthcare Conference
13/03/2019
NEW YORK, March 13, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a company focused on the development of novel immunotherapies based on proprietary chimeric antigen receptor engineered T cell ( [...]
Daxor Corporation to Showcase Reduction in Mortality and Hospital Readmissions with BVA-100® Guided-Care at the Annual Meeting of the American College of Cardiology Expo 2019
13/03/2019
NEW YORK, March 13, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement today [...]
Positive FDA Meeting Outlines Path Ahead for Akari Therapeutics’s Coversin in Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA)
13/03/2019
HSCT-TMA trial in pediatric patients expected to start Q4 2019 following recent FDA feedback NEW YORK and LONDON, March 13, 2019 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biopharmaceutical company [...]
Oncology Venture rearranges its financing agreement with EHGOS (Alpha Blue Ocean)
13/03/2019
Press release Hoersholm, Denmark, March 13, 2019 – Oncology Venture A/S (Nasdaq First North Stockholm: OV.ST) today announces a modification of the conditions of the financing agreement entered into with European High [...]
Veradigm™ Strengthens its Health Plan and Analytics Solutions by Finalizing Partnership with Pulse8
13/03/2019
CHICAGO, March 13, 2019 (GLOBE NEWSWIRE) -- Veradigm™, an Allscripts (NASDAQ: MDRX), business unit, announced today that it has strengthened its strategic relationship with Pulse8, a leader in healthcare analytics and [...]
Cedars Sinai Uses AlloSure in Tocilizumab Trial
13/03/2019
Cedars Sinai enrolls first patient in a study that uses AlloSure to characterize patient response to therapy BRISBANE, Calif., March 13, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics [...]
ALGENEX appoints new Strategic Advisory Board (SAB)
13/03/2019
PRESS RELEASE ALGENEX appoints new Strategic Advisory Board (SAB) Advisors include recognized industry leaders in international healthcare Madrid (Spain), March 13, 2019 – ALGENEX SL (the “company”), a private [...]
AIT Therapeutics to Participate at Two Investor Conferences in March
13/03/2019
GARDEN CITY, N.Y., and REHOVOT, Israel, March 13, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTCQB: AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide ( [...]
Proteon Therapeutics Announces Fourth Quarter and Full-Year 2018 Financial Results
13/03/2019
WALTHAM, Mass., March 13, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with kidney and vascular [...]
Tauriga Sciences Inc. Further Increases its Production of Tauri-Gum Inventory to Support its Ongoing Commercial Launch
13/03/2019
New York, NY, March 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and [...]
Solid Biosciences Reports Fourth Quarter and Fiscal Year 2018 Financial Results and Provides Business Update
13/03/2019
–Activities underway to commence dosing of second cohort of patients in the IGNITE DMD clinical trial at 2E14 vg/kg of SGT-001– CAMBRIDGE, Mass., March 13, 2019 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (NASDAQ: SLDB) [...]
KemPharm Provides Update on APADAZ® Formulary Adoption
13/03/2019
Conference Call Scheduled for Today, Wednesday, March 13, 2019 at 8:30 a.m. ET Highlights: According to MMIT estimates, the authorized generic for APADAZ has unrestricted formulary access for 91% of Commercial lives and [...]
Vaccinex Reports Fourth Quarter 2018 Financial Results and Provides Corporate Update
13/03/2019
Initial data from ongoing open label study of pepinemab (VX15/2503) in combination with avelumab in non-small cell lung cancer expected in 2Q 2019 Enrollment in cohort B of the Phase 2 SIGNAL Huntington’s disease trial [...]
Assembly Biosciences to Participate in the Jefferies 2019 HBV Summit
13/03/2019
SAN FRANCISCO, March 13, 2019 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases [...]
Anavex Life Sciences to Present at the 31st Annual ROTH Conference 2019
13/03/2019
NEW YORK, March 13, 2019 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of [...]
SunGen Pharma and Athenex Pharmaceutical Division Announce Busulfan Injection Product Launch
13/03/2019
PRINCETON, N.J., March 13, 2019 (GLOBE NEWSWIRE) -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products, today announced the [...]
ContraFect to Present at the Oppenheimer 29th Annual Healthcare Conference
13/03/2019
YONKERS, New York, March 13, 2019 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX) , a clinical-stage biotechnology company focused on the discovery and development of novel, differentiated biologic therapeutics [...]
Trevena Reports Fourth Quarter and Full Year 2018 Results
13/03/2019
— Company announces submission of oliceridine healthy volunteer study protocol and analysis plan to FDA — — Successful fundraising extends cash runway into 3Q 2020 — Company to host conference call today, March 13, 2019 [...]

Pages